These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6281021)

  • 1. Immunological and virological investigations in Down's syndrome.
    Fekete G; Kulcsár G; Dán P; Nász I; Schuler D; Dobos M
    Eur J Pediatr; 1982 Feb; 138(1):59-62. PubMed ID: 6281021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic and virologic studies in Down's syndrome].
    György F; Gizella K; Pál D; István N; Dezsö S; Matild D
    Orv Hetil; 1978 May; 119(19):1147-51. PubMed ID: 206865
    [No Abstract]   [Full Text] [Related]  

  • 3. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.
    Barrena MJ; Echaniz P; Garcia-Serrano C; Zubillaga P; Cuadrado E
    Clin Exp Immunol; 1992 Apr; 88(1):41-4. PubMed ID: 1348667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the levels of gamma G, gamma A, gamma M globulins, anti-A and anti-B agglutinins, and antibodies to Escherichia coli in Down's anomaly.
    Adinolfi M; Gardner B; Martin W
    J Clin Pathol; 1967 Nov; 20(6):860-4. PubMed ID: 4177796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte proliferation in Down's syndrome measured by sister chromatid differential staining.
    Crossen PE; Morgan WF
    Hum Genet; 1980; 53(3):311-3. PubMed ID: 6154638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of phospholipidolytic Candida albicans isolated from saliva of children with Down's syndrome].
    Ribeiro EL; Campos Cde C; Crespo AM; Castro JS; Rocha FP; Alves M; Goulart MS; Cardoso C; Ferreira W; Naves PL; Soares AJ; Miranda SR; Pimenta FC
    Acta Med Port; 2002; 15(3):171-4. PubMed ID: 12379993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitogen- and antigen-induced lymphocyte blastogenesis by herpes simplex virus.
    Plaeger-Marshall S; Smith JW
    J Infect Dis; 1978 Oct; 138(4):506-11. PubMed ID: 213497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
    Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
    Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome.
    Hahn T; Levin S; Handzel ZT; Ashkenazi A; Chemke J; Shterk V
    Isr J Med Sci; 1979 Sep; 15(9):775-8. PubMed ID: 159876
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
    Ilonen J; Reunanen M; Salmi A; Tiilikainen A
    J Neurol Sci; 1981 Jan; 49(1):117-33. PubMed ID: 6259296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thymic humoral factor on cellular immune factors of normal children and of pediatric patients with ataxia telangiectasia and Down's syndrome.
    Handzel ZT; Dolfin Z; Levin S; Altman Y; Hahn T; Trainin N; Gadot N
    Pediatr Res; 1979 Jul; 13(7):803-6. PubMed ID: 158166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.